NCT02883166View on ClinicalTrials.gov

Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Prostate Cancer
Interventions
DRUG

abiraterone

integested with a continental breakfast

Trial Locations (1)

6500HB

Radboud UMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02883166 - Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake | Biotech Hunter | Biotech Hunter